Member Info for bluetigeruk

Aquakidd - just to be clear to new readers who dont understand these things - yes the price of the shares will rise - to £2 etc - BUT - thats due to share consolidation and not due to any capital gain. So to be clear if i have 20 shares at 12p and they consolidate 20:1 - then the new share price is 240p - but i have 20 times fewer shares. MY old shares were worth 12p x 20 shares = 240p - my new ones are worth 240p x 1 shares = 240p. Its the same - its not a jump in the value of your shares. Thanks Blue

Multiplier - thats not how market making works at all - you dont understand it. The MM dont just sell millions of shares at their shrt book risk then pull the price back and cover to make an easy £10m. They simply take the order flow and match up against that, they are not allowed to run a huge book risk position, in fact they would get fired if they did. When the bid is strong they raise prices to find stock, when the flow slows of the offer is strong they then drop prices because the dealers are placing shares. I was a dealer in the CIty - a long time ago when we used phones and spoke to people to place trades and negotiate prices with the MM - its not gambling or big position taking, its simply offering liquidity and getting paid for it. In fact the MM dont give a monkeys if the price rises really - they just want a strong stream of steady orders (flow) to match up buyers and sellers an get paid. If they had 10M sellers and 10M buyers its a perfect day. Thanks Blue

Shorts in control !

What are you talking about - have you seen the chart over the past 3 months.

If the shorts are in control they are not doing a very good job.

The markets just not bid because there are fewer buyers around - its got nothing to do with shorts.

Thanks Blue

At £3 p/sh you have calculated the pure no risk price - so include risks into the model:

1. 4% (.04 x 3 = .12) cost of money vs 10 year

2. He price fluctuations say 0.05

3. Geological risk 0.05

4. Engineering risk 0.1

5. $50m of dilutions say 0.3

Add that up you get 0.62 of risk - so £3 x 0.62 = £1.86 - still a 7 x bagger from here and looking good. As the risk reduces - change the numbers to get a new output value.

Thanks Blue

My advice and opinion - DL is a tick, get out now while you still can - he has a terrible track record of reducing small companies to smaller ones. Just MHO // Thanks Blue

I think first / early tests are done for safety not efficacy. Thanks Blue

RNS Timings - it doesn't really matter does it - if they RNS tomorrow AM or in 2 weeks - as long as progress is in the right direction its nothing to worry about - relax / Thanks Blue

UK Market is a poor relation to NASDAQ / US money these days - many global exchanges have expanded their automatic trading offers so that trades can be matched for a dollar or less / $5 to retail - plus we have stamp duty - thats a drag on using our market - then the US pumps USD One Trillion into its economy every 100 days - any loose money then finds its way into stocks and bonds so their market is on steroids (currently). Plus our electrical energy is way too high - so UK PLC is not competitive - and markets such as the ASX TSX are competing very well for resource companies - so the traditional UK market for resources is closing too. Unfortunately our government is ed by a cabinet that does not have ANY industry or entrepreneurial experience - they all worked as communications officers for charities and unions - and they have no understanding of what global competitiveness means - so the UK is lost until we can change government. I think even the Chancellor is starting to get this after speaking to business people outside her echo chamber in Labour HQ. I think she realizes the damage is spreading. If you really want to look at the mess we are in the Business Secretary is Jonathan Reynolds - he worked for Manchester Council and then failed to complete his Law conversion and became an MP. He has never worked in business or industry.

Just bought 8500 - hello - im in Thanks Blue

Johnson & Johnson confirmed on Monday that it has agreed to buy biopharmaceutical firm Intra-Cellular Therapies for around $14.6bn.

Not really true - you just hold an EGM - how do you think companies issue shares for rights issues or takeovers?

Its good news that investors want to put their money in - i run a start up these days and if someone knocks on the door and decides to give you money - you take it. You cant run out of shares to issue - but you can always run out of money - this is a pre-revenue cash burn start up with a speculative technology - dont get over invested in it and dont be surprised if they need cash to keep the lights on. Thanks Blue

Bear Raids can often mean there is some good news coming - if you look at investment web sites they state that a BR is short sellers trying to drive down the price to cover lower and make a profit - "der!".

I have seen them used to buy shares to hold because there is good news coming - collect shares at a big discount - which is why the price recovers quickly because in fact there is not a big tranche of shares to get placed around the market. The other is to help party or parties to close out short positions - again - if they feel the price will rise against them - remember a short position has unlimited upside risk, a long position can only drop to zero. So i don't know anything - but I have a decent idea that the Bear Raid was due to some good news coming during the very limited thin trading period coming over the next 15 days, there's no exit during Christmas trading as HEMO liquidity will be minimum quoted volume required.

Also its worth reminding everyone that HEMO is a terrible small and insignificant stock to take out short positions on because the liquidity is low and the market cap tiny so it makes very little sense for any professionals to target it - as they can get caught in a bear squeeze extremely easily - its way too much risk - also professionals would target a share that can be hedged with options to give insurance cover - but that's another market. Thanks Blue

Nasty Bear Raid - it shows that HEMO should dump Peterhouse as an advisor and then just use Prevail Partners to do the Financial PR on behalf of the business - and then HEMO just gets out of the way and concentrates on the science business.

Any institutional investor adding to the cap table is good news for a loss making start up at this TRL - dont worry about the small discount - a bird in the hand etc is valuable for start ups - its far les messy than running low of cash and trying to rally around fresh money. Thanks Blue

I once worked as an assistant dealer - 30 years ago - and there was a saying - bad news comes in 3s - its

1. Bad Update

2. Then management review and a second bad Update - its worse than we thought

3. Rights Issue or Restructuring - Lay Offs etc

4. Trading is Back on Track

Its a rule of thumb - but happened time after time.

Thanks Blue

Thats £1 a share for Wood Gp and just £1 for PFC - ??

Just joking / kind of / Thanks Blue

Island G - its a sale and buy back as its officially called on a trading desk. It normally has a very tight spread and half commission too. You don't B&B shares in an ISA as they already have a tax wrapper. A B&B if i remember has to cross 2 trading days to be a true B&B - so you would sell at 3.29 and buy back at 3.31 with the MM. Or when the stock exchange ran on 2 week settlements you could also jump the next trading period by doing a roll over - which appropriately is now a lottery phrase! Thanks Blue

By non dilute funding - do you mean debt ? Does MD Anderson provide debt funding as part of its services to research trials? I see this as a huge risk even if it is ring fenced away from the original institution - plus i cant see any mention of it - I don't have a lot of information here - or any - but is that what the board is saying - MDA offers a debt instrument. Thanks Blue

Institutions dont really buy very small stocks like this - its off the radar and cant be bought by almost all trusts / pensions etc. It may be held in a small and specialist bio SME fund or something similar. With no revenue, no dividends, no large contracts etc ... its just a start-up and does not meet investment grade equities - also no options market for stock lending and hedging. So no its not being bought up by institutions. Way too small currently. Thanks Blue